Breaking News Instant updates and real-time market news.

BIO

Bio-Rad

$594.44 /

+0.09 (+0.02%)

, DGX

Quest Diagnostics

$115.77 /

-1.73 (-1.47%)

04:55
02/25/21
02/25
04:55
02/25/21
04:55

Citigroup to hold a virtual conference

2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference will be held on February 24-25.

BIO

Bio-Rad

$594.44 /

+0.09 (+0.02%)

DGX

Quest Diagnostics

$115.77 /

-1.73 (-1.47%)

DXCM

DexCom

$405.52 /

-1.49 (-0.37%)

EXAS

Exact Sciences

$135.04 /

-3.84 (-2.76%)

HOLX

Hologic

$75.15 /

-0.4 (-0.53%)

JNJ

Johnson & Johnson

$162.61 /

+2.105 (+1.31%)

MDT

Medtronic

$118.73 /

+0.71 (+0.60%)

MTD

Mettler-Toledo

$1,126.92 /

+15.75 (+1.42%)

PEN

Penumbra

$288.57 /

+8.5 (+3.03%)

PODD

Insulet

$262.39 /

+1.9 (+0.73%)

SHC

Sotera Health

$26.72 /

+0.28 (+1.06%)

SLQT

SelectQuote

$30.76 /

+0.795 (+2.65%)

TECH

Bio-Techne

$374.73 /

-2.58 (-0.68%)

TNDM

TNDM

/

+

ZBH

Zimmer Biomet

$163.78 /

+1.96 (+1.21%)

  • 25

    Feb

  • 25

    Feb

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

  • 08

    Mar

  • 08

    Mar

  • 11

    Mar

  • 11

    Mar

  • 20

    Apr

  • 21

    May

  • 13

    May

  • 21

    May

  • 28

    May

  • 20

    Nov

BIO Bio-Rad
$594.44 /

+0.09 (+0.02%)

02/12/21 Citi
Bio-Rad price target raised to $750 from $675 at Citi
02/05/21 Jefferies
Bio-Rad price target raised to $725 from $660 at Jefferies
10/30/20 Citi
Bio-Rad price target raised to $675 from $625 at Citi
10/30/20 Wells Fargo
Bio-Rad price target raised to $650 from $590 at Wells Fargo
DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
10/26/20 Mizuho
Quest Diagnostics price target raised to $149 from $144 at Mizuho
DXCM DexCom
$405.52 /

-1.49 (-0.37%)

02/12/21 Oppenheimer
DexCom price target raised to $449 from $415 at Oppenheimer
02/12/21 Citi
DexCom price target lowered to $480 from $485 at Citi
02/12/21 Piper Sandler
DexCom earnings selloff should be bought, says Piper Sandler
01/29/21 Piper Sandler
DexCom price target raised to $500 from $465 at Piper Sandler
EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

02/18/21 Baird
Exact Sciences price target lowered to $163 from $169 at Baird
02/17/21 Stifel
Exact Sciences price target raised to $165 from $150 at Stifel
02/17/21 SVB Leerink
Exact Sciences price target raised to $180 from $170 at SVB Leerink
02/17/21 Cowen
Exact Sciences price target raised to $180 from $154 at Cowen
HOLX Hologic
$75.15 /

-0.4 (-0.53%)

02/22/21 BTIG
Hologic price target raised to $91 from $84 at BTIG
01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MDT Medtronic
$118.73 /

+0.71 (+0.60%)

02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
02/24/21 Stifel
Medtronic price target raised to $135 after earnings at Stifel
02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
MTD Mettler-Toledo
$1,126.92 /

+15.75 (+1.42%)

02/05/21 Wells Fargo
Mettler-Toledo price target raised to $1,300 from $1,100 at Wells Fargo
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history
01/04/21 Evercore ISI
Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI
PEN Penumbra
$288.57 /

+8.5 (+3.03%)

02/24/21 Canaccord
Penumbra price target raised to $310 from $204 at Canaccord
02/24/21 Wells Fargo
Penumbra price target raised to $310 from $260 at Wells Fargo
02/24/21 Citi
Penumbra price target raised to $325 from $255 at Citi
12/16/20
Fly Intel: Top five analyst downgrades
PODD Insulet
$262.39 /

+1.9 (+0.73%)

02/24/21 Raymond James
Insulet price target raised to $296 from $282 at Raymond James
02/04/21 Piper Sandler
Tandem trades at 'significant discount' to Insulet, says Piper Sandler
01/29/21 Piper Sandler
Insulet downgraded to Neutral from Overweight at Piper Sandler
12/16/20 Citi
Insulet downgraded to Neutral from Buy at Citi
SHC Sotera Health
$26.72 /

+0.28 (+1.06%)

01/13/21 Baird
Sotera Health initiated with an Outperform at Baird
12/15/20 KeyBanc
Sotera Health initiated with an Overweight at KeyBanc
12/15/20 JPMorgan
Sotera Health initiated with an Overweight at JPMorgan
12/15/20 Jefferies
Sotera Health initiated with a Buy at Jefferies
SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
TECH Bio-Techne
$374.73 /

-2.58 (-0.68%)

02/23/21 Stifel
Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance
02/23/21 Stifel
Bio-Techne upgraded to Buy from Hold at Stifel
02/03/21 Craig-Hallum
Bio-Techne price target raised to $440 from $352 at Craig-Hallum
02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
TNDM TNDM
/

+

01/21/21 Citi
Citi adds Tandem, removes Guardant from 'Value Creators' list
12/15/20 Wells Fargo
Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up
12/15/20 Wells Fargo
Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

02/09/21 Piper Sandler
Zimmer Biomet multiple should move higher into spin, says Piper Sandler
02/08/21 SVB Leerink
Zimmer Biomet price target raised to $190 from $185 at SVB Leerink
02/08/21 Wells Fargo
Zimmer Biomet price target raised to $176 from $165 at Wells Fargo
02/08/21 Deutsche Bank
Zimmer Biomet price target raised to $160 from $146 at Deutsche Bank

TODAY'S FREE FLY STORIES

Hot Stocks
Volaris announces further liquidity preservation measures » 18:31
04/14/21
04/14
18:31
04/14/21
18:31
VLRS

Volaris

$15.39 /

-0.265 (-1.69%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VLRS Volaris
$15.39 /

-0.265 (-1.69%)

VLRS Volaris
$15.39 /

-0.265 (-1.69%)

04/11/21 Goldman Sachs
Volaris price target raised to $20.10 from $13 at Goldman Sachs
03/05/21 Citi
Volaris price target raised to $18.25 from $15.75 at Citi
02/22/21 Barclays
Volaris price target raised to $18 from $14 at Barclays
02/22/21 Deutsche Bank
Volaris upgraded to Buy from Hold at Deutsche Bank
VLRS Volaris
$15.39 /

-0.265 (-1.69%)

  • 09
    Dec
Hot Stocks
Ralph Lauren CFO sells 10.6K shares of common stock » 18:29
04/14/21
04/14
18:29
04/14/21
18:29
RL

Ralph Lauren

$125.80 /

+1.485 (+1.19%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RL Ralph Lauren
$125.80 /

+1.485 (+1.19%)

RL Ralph Lauren
$125.80 /

+1.485 (+1.19%)

04/01/21 Citi
PVH Corp. price target raised to $112 from $105 at Citi
02/05/21 Barclays
Ralph Lauren price target raised to $109 from $72 at Barclays
02/01/21 Needham
Ralph Lauren price target raised to $112 from $82 at Needham
01/26/21 Piper Sandler
Ralph Lauren price target raised to $103 from $74 at Piper Sandler
RL Ralph Lauren
$125.80 /

+1.485 (+1.19%)

RL Ralph Lauren
$125.80 /

+1.485 (+1.19%)

RL Ralph Lauren
$125.80 /

+1.485 (+1.19%)

Hot Stocks
Guardant Health CEO sells 239.6K shares of common stock » 18:27
04/14/21
04/14
18:27
04/14/21
18:27
GH

Guardant Health

$155.11 /

-1.77 (-1.13%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GH Guardant Health
$155.11 /

-1.77 (-1.13%)

GH Guardant Health
$155.11 /

-1.77 (-1.13%)

02/25/21 Cowen
Guardant Health price target raised to $190 from $140 at Cowen
02/25/21 Citi
Guardant Health price target raised to $190 from $155 at Citi
01/21/21 Citi
Citi adds Tandem, removes Guardant from 'Value Creators' list
01/14/21 Canaccord
Natera price target raised to $125 from $112 at Canaccord
GH Guardant Health
$155.11 /

-1.77 (-1.13%)

  • 07
    Oct
  • 02
    Jun
GH Guardant Health
$155.11 /

-1.77 (-1.13%)

Hot Stocks
Titan Machinery CEO sells 360K shares of common stock » 18:25
04/14/21
04/14
18:25
04/14/21
18:25
TITN

Titan Machinery

$26.18 /

-0.2 (-0.76%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TITN Titan Machinery
$26.18 /

-0.2 (-0.76%)

TITN Titan Machinery
$26.18 /

-0.2 (-0.76%)

11/25/20 Craig-Hallum
Titan Machinery price target raised to $23 from $17 at Craig-Hallum
11/24/20 Baird
Titan Machinery price target raised to $25 from $21 at Baird
10/21/20 William Blair
Titan Machinery upgraded to Outperform from Market Perform at William Blair
TITN Titan Machinery
$26.18 /

-0.2 (-0.76%)

TITN Titan Machinery
$26.18 /

-0.2 (-0.76%)

Hot Stocks
Ian Walsh replaces retiring Kaman board Chairman Neal Keating » 18:20
04/14/21
04/14
18:20
04/14/21
18:20
KAMN

Kaman

$52.90 /

+0.44 (+0.84%)

Kaman announced that Neal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KAMN Kaman
$52.90 /

+0.44 (+0.84%)

KAMN Kaman
$52.90 /

+0.44 (+0.84%)

Syndicate
Agilon Health 46.6M share IPO priced at $23.00 » 18:16
04/14/21
04/14
18:16
04/14/21
18:16
AGL

Agilon Health

/

+

The deal priced at high…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 15
    Apr
AGL Agilon Health
/

+

On The Fly
Fly Intel: After-Hours Movers » 18:15
04/14/21
04/14
18:15
04/14/21
18:15
AEO

American Eagle

$32.98 /

+0.44 (+1.35%)

, CMPR

Cimpress

$105.00 /

+0.7098 (+0.68%)

, APXT

Apex Technology Acquisition

$11.18 /

+0.02 (+0.18%)

, DELL

Dell Technologies

$92.70 /

+0.16 (+0.17%)

, VMW

VMware

$155.52 /

+1.28 (+0.83%)

, ORC

Orchid Island Capital

$6.14 /

-0.035 (-0.57%)

, ETH

Ethan Allen

$27.59 /

+0.12 (+0.44%)

, MAXN

Maxeon Solar

$22.87 /

+0.26 (+1.15%)

, GBX

Greenbrier

$46.13 /

+0.59 (+1.30%)

Check out this evening's…

ShowHide Related Items >><<
AEO American Eagle
$32.98 /

+0.44 (+1.35%)

CMPR Cimpress
$105.00 /

+0.7098 (+0.68%)

APXT Apex Technology Acquisition
$11.18 /

+0.02 (+0.18%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

VMW VMware
$155.52 /

+1.28 (+0.83%)

ETH Ethan Allen
$27.59 /

+0.12 (+0.44%)

MAXN Maxeon Solar
$22.87 /

+0.26 (+1.15%)

GBX Greenbrier
$46.13 /

+0.59 (+1.30%)

AEO American Eagle
$32.98 /

+0.44 (+1.35%)

03/09/21 Morgan Stanley
American Eagle price target raised to $25 from $18 at Morgan Stanley
03/04/21 B. Riley Securities
American Eagle price target raised to $32 from $30 at B. Riley Securities
03/04/21 Jefferies
American Eagle price target raised to $32 after 'strong quarter' at Jefferies
03/04/21 UBS
American Eagle price target raised to $37 from $31 at UBS
CMPR Cimpress
$105.00 /

+0.7098 (+0.68%)

02/03/21 Barrington
Cimpress longer-term thesis intact despite profitability miss, says Barrington
01/29/21 Truist
Cimpress price target raised to $124 from $112 at Truist
08/17/20 Barrington
Cimpress upgraded to Outperform from Market Perform at Barrington
07/30/20 SunTrust
Cimpress upgraded to Buy from Hold at SunTrust
APXT Apex Technology Acquisition
$11.18 /

+0.02 (+0.18%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

04/13/21
Morgan Stanley IT hardware analyst to hold analyst/industry conference call
04/08/21 Morgan Stanley
Dell Technologies price target raised to $107 from $98 at Morgan Stanley
04/07/21 Deutsche Bank
Dell Technologies price target raised to $100 from $94 at Deutsche Bank
02/26/21 JPMorgan
Dell Technologies price target raised to $98 from $90 at JPMorgan
VMW VMware
$155.52 /

+1.28 (+0.83%)

04/08/21 BofA
VMware reinstated with a Neutral at BofA
04/08/21 BofA
VMware reinstated with a Neutral at BofA
03/15/21 Credit Suisse
VMware assumed with a Neutral at Credit Suisse
03/03/21 Citi
VMware assumed with a Buy at Citi
ORC Orchid Island Capital
$6.14 /

-0.035 (-0.57%)

10/30/20 Ladenburg
Orchid Island Capital upgraded to Buy from Neutral at Ladenburg
ETH Ethan Allen
$27.59 /

+0.12 (+0.44%)

11/24/20 UBS
RH price target raised to $450 from $380 at UBS
MAXN Maxeon Solar
$22.87 /

+0.26 (+1.15%)

04/12/21 Roth Capital
Maxeon Solar downgraded to Neutral from Buy at Roth Capital
04/12/21 Roth Capital
Maxeon Solar downgraded to Neutral from Buy at Roth Capital
02/08/21 Roth Capital
Bill could be 'meaningful positive' for solar stocks, says Roth Capital
01/19/21 Roth Capital
Maxeon Solar initiated with a Buy at Roth Capital
GBX Greenbrier
$46.13 /

+0.59 (+1.30%)

12/14/20 Wells Fargo
Greenbrier upgraded to Overweight from Underweight at Wells Fargo
08/27/20
Fly Intel: Top five analyst downgrades
08/27/20 KeyBanc
Greenbrier downgraded at KeyBanc on slow rebound in domestic railcar orders
08/27/20 KeyBanc
Greenbrier downgraded to Sector Weight from Overweight at KeyBanc
AEO American Eagle
$32.98 /

+0.44 (+1.35%)

CMPR Cimpress
$105.00 /

+0.7098 (+0.68%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

VMW VMware
$155.52 /

+1.28 (+0.83%)

ORC Orchid Island Capital
$6.14 /

-0.035 (-0.57%)

ETH Ethan Allen
$27.59 /

+0.12 (+0.44%)

MAXN Maxeon Solar
$22.87 /

+0.26 (+1.15%)

GBX Greenbrier
$46.13 /

+0.59 (+1.30%)

  • 16
    Apr
  • 03
    Mar
  • 21
    Jan
AEO American Eagle
$32.98 /

+0.44 (+1.35%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

VMW VMware
$155.52 /

+1.28 (+0.83%)

AEO American Eagle
$32.98 /

+0.44 (+1.35%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

VMW VMware
$155.52 /

+1.28 (+0.83%)

ORC Orchid Island Capital
$6.14 /

-0.035 (-0.57%)

ETH Ethan Allen
$27.59 /

+0.12 (+0.44%)

MAXN Maxeon Solar
$22.87 /

+0.26 (+1.15%)

GBX Greenbrier
$46.13 /

+0.59 (+1.30%)

AEO American Eagle
$32.98 /

+0.44 (+1.35%)

APXT Apex Technology Acquisition
$11.18 /

+0.02 (+0.18%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

VMW VMware
$155.52 /

+1.28 (+0.83%)

MAXN Maxeon Solar
$22.87 /

+0.26 (+1.15%)

Periodicals
Dell Technologies considering sale of Boomi Cloud business, Bloomberg says » 18:13
04/14/21
04/14
18:13
04/14/21
18:13
DELL

Dell Technologies

$92.70 /

+0.16 (+0.17%)

Dell Technologies is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

04/13/21
Morgan Stanley IT hardware analyst to hold analyst/industry conference call
04/08/21 Morgan Stanley
Dell Technologies price target raised to $107 from $98 at Morgan Stanley
04/07/21 Deutsche Bank
Dell Technologies price target raised to $100 from $94 at Deutsche Bank
02/26/21 JPMorgan
Dell Technologies price target raised to $98 from $90 at JPMorgan
DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

Hot Stocks
Bentley Systems to acquire INRO Software » 18:11
04/14/21
04/14
18:11
04/14/21
18:11
BSY

Bentley Systems

$49.76 /

-0.21 (-0.42%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BSY Bentley Systems
$49.76 /

-0.21 (-0.42%)

BSY Bentley Systems
$49.76 /

-0.21 (-0.42%)

03/10/21
Fly Intel: Top five analyst upgrades
03/10/21 KeyBanc
Bentley Systems upgraded to Overweight with $52 target at KeyBanc
03/09/21 KeyBanc
Bentley Systems upgraded to Overweight from Sector Weight at KeyBanc
03/03/21 Mizuho
Bentley Systems price target raised to $53 from $50 at Mizuho
BSY Bentley Systems
$49.76 /

-0.21 (-0.42%)

  • 13
    Nov
  • 23
    Sep
BSY Bentley Systems
$49.76 /

-0.21 (-0.42%)

Hot Stocks
AvePoint to buy up to $20M in Apex Technology Acquisition » 18:08
04/14/21
04/14
18:08
04/14/21
18:08
APXT

Apex Technology Acquisition

$11.18 /

+0.02 (+0.18%)

AvePoint also reports…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APXT Apex Technology Acquisition
$11.18 /

+0.02 (+0.18%)

APXT Apex Technology Acquisition
$11.18 /

+0.02 (+0.18%)

Conference/Events
Jefferies personal/household analyst to hold analyst/industry conference call » 17:58
04/14/21
04/14
17:58
04/14/21
17:58

Personal & Household…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Jefferies software/Internet analyst to hold analyst/industry conference call » 17:55
04/14/21
04/14
17:55
04/14/21
17:55
WDAY

Workday

$259.65 /

-6.11 (-2.30%)

, NKE

Nike

$132.24 /

-1.23 (-0.92%)

Software & Internet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WDAY Workday
$259.65 /

-6.11 (-2.30%)

NKE Nike
$132.24 /

-1.23 (-0.92%)

WDAY Workday
$259.65 /

-6.11 (-2.30%)

03/17/21 Canaccord
Workday price target raised to $300 from $265 at Canaccord
03/15/21 Credit Suisse
Workday assumed with a Neutral at Credit Suisse
03/09/21 JPMorgan
Workday added to Analyst Focus List at JPMorgan
03/08/21 Morgan Stanley
Software industry rating raised to Attractive from In-Line at Morgan Stanley
NKE Nike
$132.24 /

-1.23 (-0.92%)

03/31/21 HSBC
Nike price target raised to $162 from $158 at HSBC
03/30/21 Oppenheimer
Nike's China issues likely to resolve, says Oppenheimer
03/26/21
Fly Intel: Top five analyst upgrades
03/26/21 Baird
Baird upgrades Nike after two years, sees concerns as temporary
WDAY Workday
$259.65 /

-6.11 (-2.30%)

NKE Nike
$132.24 /

-1.23 (-0.92%)

NKE Nike
$132.24 /

-1.23 (-0.92%)

WDAY Workday
$259.65 /

-6.11 (-2.30%)

NKE Nike
$132.24 /

-1.23 (-0.92%)

WDAY Workday
$259.65 /

-6.11 (-2.30%)

NKE Nike
$132.24 /

-1.23 (-0.92%)

Conference/Events
UBS aerospace analyst to hold analyst/industry conference call » 17:50
04/14/21
04/14
17:50
04/14/21
17:50

Aerospace Analyst Walton…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
Dell Technologies considering sale of Boomi Cloud business, Bloomberg says » 17:48
04/14/21
04/14
17:48
04/14/21
17:48
DELL

Dell Technologies

$92.70 /

+0.16 (+0.17%)

The assets are said to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

04/13/21
Morgan Stanley IT hardware analyst to hold analyst/industry conference call
04/08/21 Morgan Stanley
Dell Technologies price target raised to $107 from $98 at Morgan Stanley
04/07/21 Deutsche Bank
Dell Technologies price target raised to $100 from $94 at Deutsche Bank
02/26/21 JPMorgan
Dell Technologies price target raised to $98 from $90 at JPMorgan
DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

DELL Dell Technologies
$92.70 /

+0.16 (+0.17%)

Conference/Events
Morgan Stanley paper/packaging analyst to hold analyst/industry conference call » 17:46
04/14/21
04/14
17:46
04/14/21
17:46

Paper & Packaging…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Morgan Stanley Euro capital goods analysts hold analyst/industry conference call » 17:43
04/14/21
04/14
17:43
04/14/21
17:43

European Capital Goods…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Periodicals
Top White House officials to discuss vaccine rollout with House, CNBC says » 17:41
04/14/21
04/14
17:41
04/14/21
17:41
JNJ

Johnson & Johnson

$159.95 /

+0.44 (+0.28%)

, PFE

Pfizer

$37.16 /

+0.01 (+0.03%)

, BNTX

BioNTech

$132.52 /

+3.11 (+2.40%)

, MRNA

Moderna

$160.10 /

+10.62 (+7.10%)

, SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$411.49 /

-1.34 (-0.32%)

The House coronavirus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$159.95 /

+0.44 (+0.28%)

PFE Pfizer
$37.16 /

+0.01 (+0.03%)

BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

MRNA Moderna
$160.10 /

+10.62 (+7.10%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$411.49 /

-1.34 (-0.32%)

JNJ Johnson & Johnson
$159.95 /

+0.44 (+0.28%)

10:59 Today Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
PFE Pfizer
$37.16 /

+0.01 (+0.03%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
MRNA Moderna
$160.10 /

+10.62 (+7.10%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
SPX S&P 500
/

+

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
SPY SPDR S&P 500 ETF Trust
$411.49 /

-1.34 (-0.32%)

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
JNJ Johnson & Johnson
$159.95 /

+0.44 (+0.28%)

PFE Pfizer
$37.16 /

+0.01 (+0.03%)

MRNA Moderna
$160.10 /

+10.62 (+7.10%)

SPX S&P 500
/

+

  • 23
    Jul
  • 19
    May
JNJ Johnson & Johnson
$159.95 /

+0.44 (+0.28%)

PFE Pfizer
$37.16 /

+0.01 (+0.03%)

BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

MRNA Moderna
$160.10 /

+10.62 (+7.10%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$411.49 /

-1.34 (-0.32%)

JNJ Johnson & Johnson
$159.95 /

+0.44 (+0.28%)

PFE Pfizer
$37.16 /

+0.01 (+0.03%)

BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

MRNA Moderna
$160.10 /

+10.62 (+7.10%)

JNJ Johnson & Johnson
$159.95 /

+0.44 (+0.28%)

PFE Pfizer
$37.16 /

+0.01 (+0.03%)

BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

MRNA Moderna
$160.10 /

+10.62 (+7.10%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$411.49 /

-1.34 (-0.32%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$411.49 /

-1.34 (-0.32%)

Hot Stocks
Novavax to participate in University of Oxford Com-COV2 study » 17:41
04/14/21
04/14
17:41
04/14/21
17:41
NVAX

Novavax

$201.46 /

+6.675 (+3.43%)

Novavax announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVAX Novavax
$201.46 /

+6.675 (+3.43%)

NVAX Novavax
$201.46 /

+6.675 (+3.43%)

03/26/21 B. Riley Securities
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/22/21 Cantor Fitzgerald
Cantor says PREVENT-19 gives Novavax potential for differentiated analyses
NVAX Novavax
$201.46 /

+6.675 (+3.43%)

NVAX Novavax
$201.46 /

+6.675 (+3.43%)

NVAX Novavax
$201.46 /

+6.675 (+3.43%)

NVAX Novavax
$201.46 /

+6.675 (+3.43%)

Syndicate
Harbor Custom Development files to sell 1M convertible shares, 3M warrants » 17:35
04/14/21
04/14
17:35
04/14/21
17:35
HCDI

Harbor Custom Development

$3.06 /

-0.06 (-1.92%)

Harbor Custom Development…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCDI Harbor Custom Development
$3.06 /

-0.06 (-1.92%)

HCDI Harbor Custom Development
$3.06 /

-0.06 (-1.92%)

  • 13
    Jan
  • 07
    Aug
HCDI Harbor Custom Development
$3.06 /

-0.06 (-1.92%)

Periodicals
CDC panel ends meeting w/out vote on Johnson & Johnson's vaccine, Bloomberg says » 17:31
04/14/21
04/14
17:31
04/14/21
17:31
JNJ

Johnson & Johnson

$159.95 /

+0.44 (+0.28%)

The report states that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$159.95 /

+0.44 (+0.28%)

JNJ Johnson & Johnson
$159.95 /

+0.44 (+0.28%)

10:59 Today Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
JNJ Johnson & Johnson
$159.95 /

+0.44 (+0.28%)

JNJ Johnson & Johnson
$159.95 /

+0.44 (+0.28%)

JNJ Johnson & Johnson
$159.95 /

+0.44 (+0.28%)

JNJ Johnson & Johnson
$159.95 /

+0.44 (+0.28%)

Conference/Events
Federal Reserve Bank of Dallas president participates in a virtual event » 17:25
04/14/21
04/14
17:25
04/14/21
17:25

Dallas Federal Reserve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Orchid Island Capital sees Q1 EPS (34c) with items, consensus 26c » 17:24
04/14/21
04/14
17:24
04/14/21
17:24
ORC

Orchid Island Capital

$6.14 /

-0.035 (-0.57%)

Q1 EPS view including an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ORC Orchid Island Capital
$6.14 /

-0.035 (-0.57%)

10/30/20 Ladenburg
Orchid Island Capital upgraded to Buy from Neutral at Ladenburg
ORC Orchid Island Capital
$6.14 /

-0.035 (-0.57%)

  • 03
    Mar
  • 21
    Jan
ORC Orchid Island Capital
$6.14 /

-0.035 (-0.57%)

Hot Stocks
GlaxoSmithKline to stop enrolling patients in phase 2 feladilimab trial » 17:23
04/14/21
04/14
17:23
04/14/21
17:23
GSK

GlaxoSmithKline

$36.12 /

+0.075 (+0.21%)

GlaxoSmithKline plc…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$36.12 /

+0.075 (+0.21%)

GSK GlaxoSmithKline
$36.12 /

+0.075 (+0.21%)

03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
03/23/21 SVB Leerink
GlaxoSmithKline downgraded to Market Perform from Outperform at SVB Leerink
03/08/21 JPMorgan
JPMorgan double downgrades AnaptysBio back to Underweight after trial miss
GSK GlaxoSmithKline
$36.12 /

+0.075 (+0.21%)

GSK GlaxoSmithKline
$36.12 /

+0.075 (+0.21%)

GSK GlaxoSmithKline
$36.12 /

+0.075 (+0.21%)

Hot Stocks
Maxeon Solar drops 6% to $21.51 after $125M offering of ordinary shares  17:11
04/14/21
04/14
17:11
04/14/21
17:11
MAXN

Maxeon Solar

$22.87 /

+0.26 (+1.15%)

 
ShowHide Related Items >><<
MAXN Maxeon Solar
$22.87 /

+0.26 (+1.15%)

MAXN Maxeon Solar
$22.87 /

+0.26 (+1.15%)

04/12/21 Roth Capital
Maxeon Solar downgraded to Neutral from Buy at Roth Capital
04/12/21 Roth Capital
Maxeon Solar downgraded to Neutral from Buy at Roth Capital
02/08/21 Roth Capital
Bill could be 'meaningful positive' for solar stocks, says Roth Capital
01/19/21 Roth Capital
Maxeon Solar initiated with a Buy at Roth Capital
MAXN Maxeon Solar
$22.87 /

+0.26 (+1.15%)

MAXN Maxeon Solar
$22.87 /

+0.26 (+1.15%)

MAXN Maxeon Solar
$22.87 /

+0.26 (+1.15%)

General news
Treasury Market Summary » 17:10
04/14/21
04/14
17:10
04/14/21
17:10
$ECON

Economic Data

/

+

Treasury Market Summary:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.